Inside Kyron.bio’s Bold Bet to Rewrite the Rules of Antibody Drug Design
For all the buzz around antibody therapies, one overlooked culprit keeps holding them back: sugars. Paris-based Kyron.bio is tackling the hidden complexity of glycosylation — the way sugars attach to therapeutic proteins — with a platform that promises safer, longer-lasting drugs.
Related
Rift Takes Flight: Drone Startup Wants To Be Europe's Eyes in the Sky
Rift raised €4.6M for its on-demand aerial surveillance network of autonomous long-endurance drones that provide governments and operators instant, low-cost “intelligence as a service” as Europe seeks faster, safer ways to monitor and protect critical territory.
Atomico Vs Pitchbook 2025 Street Fight: Is Europe’s Tech Glass Half Full or Empty?
Two reports, two moods: Atomico sees sunshine and a trillion-euro tech titan on the horizon. PitchBook forecasts storm clouds and a stress ball. European tech in 2025 is a sloppy mess with big dreams and a terrible hangover, but a can-do attitude if it can just stop tripping over itself.
Can Volta Bring B2B Commerce Out Of The Stone Age with AI?
While B2C perfected one-click buying, B2B distributors still swim in PDFs and Excel sheets. French-Italian startup Volta just raised €11M to change that. Fast.
From Cavemen to Conversational AI: GetVocal and the Human-Agentic Voice Renaissance
GetVocal raised a $26M Series A to fuel a new era of human-guided, agentic voice AI. Its system blends ancient communication instincts with cutting-edge tech to deliver trusted, enterprise-ready automation.
Latest
French Tech Funding Wire December 1: 400 RetailTech Startups; Pennylane Funding Rumors; €131M Raised In 15 Rounds
Between Nov 24 and Nov 28, French Tech startups raising VC included Zadient Technologies, AFYREN, Lexip (formerly Pixminds), Water Horizon, Damae Medical, VESTO, Alkion BioInnovations, Ventuno Biotech, Sim&Cure, AURA AERO, Komia, AberActives, Drive Innov, VoilaChef, AlgenScribe, and IvySpec.
🇫🇷 French Tech Wire: AI Agents Putting A Smile On Dentists' Faces
Members of the Doctolib mafia have a new startup, La Fraise, that dentists and their patients can't refuse. We're looking over a new Future of Work fund called Clover. Revaia takes the ESG pulse. And Jolt is raising a €1B fund to make startup rhinoceroses a thing.
Ex-Doctolib Team Deploys AI Agents To Fix France's Dysfunctional Dental System
La Fraise recently raised €3.2M to boost the nation's low quote acceptance rate by using AI to create greater transparency for recommended procedures.
Spotlight Interview: Hugo Mendes, Co-Founder of New Future of Work VC Fund Clover
Meet the evergreen VC for the Future of work that wants to re-write VC the rulebook.